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Abstract
The Mycobacterium tuberculosis stress response factor SigH plays a crucial role in modulating the pathogen’s response to
heat, oxidative-stress, envelope damage and hypoxia. We hypothesized that the lack of this key stress response factor would
alter the interaction between the pathogen and its host cells. We compared the interaction of Mtb, Mtb:D-sigH and a strain
where the mutation had been genetically complemented (Mtb: D-sigH:CO) with primary rhesus macaque bone marrow
derived macrophages (Rh-BMDMs). The expression of numerous inducible and homeostatic (CCL) b-chemokines and several
apoptotic markers was induced to higher levels in the cells infected with Mtb:D-sigH, relative to Mtb or the complemented
strain. The differential expression of these genes manifested into functional differences in chemotaxis and apoptosis in cells
infected with these two strains. The mutant strain also exhibited reduced late-stage survival in Rh-BMDMs. We hypothesize
that the product of one or more SigH-dependent genes may modulate the innate interaction of Mtb with host cells,
effectively reducing the chemokine-mediated recruitment of immune effector cells, apoptosis of infected monocytes and
enhancing the long-term survival and replication of the pathogen in this milieu The significantly higher induction of
Prostaglandin Synthetase 2 (PTGS2 or COX2) in Rh-BMDMs infected with Mtb relative to Mtb: D-sigH may explain reduced
apoptosis in Mtb-infected cells, as PTGS2 is known to inhibit p53-dependent apoptosis.The SigH-regulon modulates the
innate interaction of Mtb with host phagocytes, perhaps as part of a strategy to limit its clearance and prolong its survival.
The SigH regulon appears to be required to modulate innate immune responses directed against Mtb.
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Introduction
TB, a major cause of infectious disease mortality in humans, is
responsible for the death of over 1.7 million people every year [1].
This situation is exacerbated by the emergence of drug-resistant
strains of Mtb [2], AIDS co-infection [3] and the failure of Bacille
Calmette-Guerin (BCG) vaccine [4]. To develop effective anti-TB
drugs and vaccines, the mechanisms that help establish a long-
term infection by Mtb need to be better defined.
Mtb uses various strategies to survive within the host, including
subversion of phagosome development by secreting effector
molecules [5]; the modulation of cytokine expression by secreting
immune-modulatory molecules into the cytoplasm of Mtb-infected
macrophages [6]; the modulation of immune signaling pathways
by pumping cyclic AMP using a bacterial adenylate cyclase [7];
and the induction of matrix metalloprotease (MMP9) expression
by a secreted mycobacterial protein, - a process essential for the
initiation of granuloma formation [8].
The Mtb alternate sigma factor, SigH, is induced after heat,
redox and acid stress [9], [10], [11], [12] and phagocytosis [13],
[14]. An isogenic D-sigH mutant is attenuated for pathology in a
mouse model [9] and for both pathology and bacterial replication
in a macaque model [15]. SigH directs the transcription of 31
genes, including those which encode ECF sigma factors SigE and
SigB and proteins involved in the maintenance of intrabacterial
reducing capacity [9], [10]. Indirectly, SigH may influence the
transcription of about one-fifth of the entire Mtb genome including
those involved in ATP-dependent Clp proteolysis, mammalian cell
entry and sulfate utilization [16]. SigH is also a member of the
enduring hypoxia response [17] as well as the re-aeration response
[18], indicating that members of the extended SigH-regulon may
play a role in hypoxia stress defense and perhaps in the
reactivation of latent infection. The SigH-dependent Clp prote-
olysis pathway has recently been implicated in defense against
envelope damage [19], [20], [21].
PLoS ONE | www.plosone.org 1 January 2012 | Volume 7 | Issue 1 | e28958These results suggest that SigH controls the expression of genes
critical to the intracellular survival of Mtb. In support of this
argument, a member of the extended SigH-regulon, Rv2745c
(ClgR) is necessary for the successful infection of host phagocytes
[22]. We therefore compared the host response to infection with
the isogenic Mtb:D-sigH mutant relative to strains containing
functional copy of SigH. Towards this study, we chose bone
marrow derived macrophages (BMDMs) from rhesus macaques
(Macaca mulatta). Rhesus macaques have been extensively used as
experimental models of natural infection with Mtb [15,23–25].
Rhesus macaques accurately represent the various aspects of
human TB including acute [15,23,24] or latent TB and its
reactivation by AIDS co-infection [25].
Results
Infection of Rh-BMDMs with Mtb, the Mtb:D-sigH mutant
and the Mtb:D-sigH:Co complemented strains
Rh-BMDMs were generated by culturing cells from the bone-
marrow of several healthy, normal Indian-origin rhesus (Macaca
mulatta) collected at euthanasia. The macrophage phenotype of
the Rh-BMDMs was characterized by multi-label confocal
microscopy by staining with anti- Ham56, CD68 and CD163
antibodies (Figure S1) and flow-cytometry as previously
described [14].
Rh-BMDMs were infected for four hours with tubercle bacilli at
an MOI of 1:10, as previously described [14]. Samples were then
processed for the 0 hr post-infection time-point, or further
cultured for the 4, 24, 48 and 72 hours post-infection time-points.
All three strains infected Rh-BMDMs to comparable levels, as
assessed by the measurement of viable cfu’s at 0 hr post-infection
(Figure 1). The three strains replicated to comparable extent in
Rh-BMDMs initially, increasing about a one-half log in total
number during the course of 24 hrs. However, at the late stage
(72 hr post-infection), a significantly higher bacterial burden was
present in cells infected with Mtb, relative to the Mtb:D-sigH
mutant. The decline in Mtb:D-sigH cfu’s was directly related to the
loss of a functional SigH regulon, since the cfu burden in cells
infected with the Mtb:D-sigH:CO complemented strain was
comparable to the parental Mtb strain.
The global transcriptomic response of Rh-BMDM cells to
infection with Mtb, Mtb:D-sigH and Mtb:D-sigH:CO
To study the impact of the SigH regulon on host phagocytes, we
compared the transcriptome profiles of uninfected Rh-BMDMs to
those infected with Mtb or the Mtb: D-sigH mutant strain, at all
three time-points (cultured 0, 4 or 24 hr after the end of the four
hr infection). When transcription in distinct biological replicates of
uninfected Rh-BMDMs was compared, very small number of
genes (21 at 0 hr, 20 at 4 hr and 76 at 24 hr) showed an alteration
in expression by more than 2-fold. These data serve as controls to
which the effect of experimental infection with the different strains
can be compared.
When biological replicates of Rh-BMDMs infected with Mtb
were compared to uninfected cells, the expression of 370 genes was
induced .2-fold in a statistically significant manner at 0 hrs post-
infection time-point, (Table S1-A)and he genes with the greatest
induction included CCL20 (5.8-fold), IL8 (3.6-fold), CCL4 (3.6-
fold) and CCL7 (2.9-fold).
At the 4 hr time-point, the expression of 180 genes was
significantly induced as a result of Mtb infection (Table S1-B).
Among the genes with the greatest induction at this time-point
were CXCL1 (46.9-fold), CXCL3 (31.6-fold), PTGS2 (31.5-fold),
CXCL6 (24-fold), CXCR4 (22.8-fold), CXCL2 (10-fold), CCL2
(4-fold) and CCL7 (3.8-fold).
At the 24 hr time-point, the expression of 475 genes was
significantly induced as a result of Mtb infection (Table S1-C)The
list of genes with .2-fold induction following Mtb infection at this
time-point included PTGS2 (76-fold), CXCL6 (50-fold), CXCL3
(43-fold), CXCL1 (43-fold), CCL2 (38-fold), CCL5 (25-fold),
CXCL11 (19-fold), CCL7 (18-fold), and CCL11 (8-fold).
The expression of 277 genes was induced .2-fold in a
statistically significant manner by infection with Mtb:D-sigHa t
the 0 hr time-point(TableS1-D) Some of the genes with the
greatest induction included CCL4 (17.6-fold), CXCL2 (10-fold),
CCL7 (6.5-fold) and CCL20 (4.3-fold).
Figure 1. Comparison of infection of Rh-BMDM with Mtb, Mtb:D-sigH and Mtb:D-sigH:CO. Growth progression of the infection by Mtb, the
Mtb:D-sigH mutant and the mutant-complemented strain in Rh-BMDMs over the course of time measured by CFU analysis. The figure shows the
arithmetic means 6 standard deviations for two biological replicate experiments, with each replicate data comprising of a summarized value from
different relevant dilutions and multiple platings.
doi:10.1371/journal.pone.0028958.g001
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significantly induced by more than 2-fold as a result of Mtb: D-
sigH infection (Table S1-E). The genes with the greatest induction
at this time-point were CXCL1 (45-fold), CXCL6 (18-fold),
CXCL3 (13-fold), CCL2 (13-fold) andCXCL2 (10-fold).
At the 24 hr time-point, the expression of 607 genes was
significantly induced by more than 2-fold as a result of infection
with the mutant (Table S1-F). The list of genes with the greatest
induction following Mtb:D-sigH infection at this time-point
included CXCL1 (120-fold), PTGS2 (100-fold), CXCL6 (75-fold),
CCL2 (53-fold), CXCL3 (40-fold), CXCL1 (43-fold) and CCL2
(38-fold) CCL5 (35-fold).
Following infection with a strain where the mutation in the sigH
gene was genetically complemented, the expression of 119 genes
was induced .2-fold in a statistically significant manner at the
0 hr time-point (TableS1-G) Some of the genes with the greatest
induction included CXCL2 (29-fold), CXCL6 (16-fold), CCL7
(11-fold) CXCL1 (6-fold), CCL3 (5-fold) and CCL4 (3-fold).
At the 4 hr time-point, the expression of 189 rhesus genes was
significantly induced as a result of infection with the complement-
ed strain (Table S1-H) relative to uninfected cells. The genes with
the greatest induction at this time-point were CXCL6 (58-fold),
CXCL1 (57-fold), CXCL2 (15-fold), CXCL3 (7-fold), CXCL10 (7-
fold), CXCL7 (6-fold) and CCL7 (3-fold).
At the 24 hr time-point, the expression of 463 rhesus genes was
significantly induced as a result of infection with the complement-
ed strain (Table S1-I). This list included CXCL1 (30-fold),
CXCL6 (29-fold), CXCL3 (10-fold), CCL7 (4-fold) and CCL19
(3-fold).
A number of genes exhibited overlapping induction or
repression at different time-points. Therefore we have identified
all genes which exhibited such overlapping expression following
infection with either Mtb or the mutant (Table S2 B).
The expression of several b-chemokine genes was differentially
expressed following infection with the mutant, relative to either
Mtb or the complemented strain. The expression of CCL4
appeared to be significantly higher in cells infected with the
Mtb:D-sigH mutant relative to either Mtb or the complement, at
the 0 hr post-infection time-point, while the expression of CCL2,
CCL5 and CCL7 appeared to be significantly higher in cells
infected with the mutant relative to Mtb or the complemented
strain, at 4 hrs post-infection. The expression of CCL13, CCL19
and CXCL1 was significantly higher in cells infected with the
Mtb:D-sigH mutant relative to Mtb or Mtb:D-sigH:CO at 24 hrs
post-infection (Table S1 B).
We therefore systematically investigated the expression of
various chemokines and their receptors. The expression of several
b-chemokines was induced at high levels in cells infected with the
Mtb:D-sigH mutant. For example, the expression of CCL2, CCL4
and CCL7 was induced to higher levels in cells infected with the
Mtb:D-sigH mutant (4.18, 6.23 and 4.3-fold respectively), relative
to cells infected with Mtb (1.9, 3.5 and 2.9-fold respectively) or
Mtb:D-sigH:CO (1.7, 3.3 and 3.7-fold respectively), at the 0 hr
post-infection time-point (Figure 2A). Similarly, the expression of
CCL2, CCL5 and CCL7 was induced to higher levels in cells
infected with the Mtb:D-sigH mutant (13.17, 2.2 and 9.2-fold
respectively), relative to cells infected with Mtb (4.1, 0.68 and 3.8-
fold respectively) or Mtb:D-sigH:CO (1.9, 1.8 and 3.8 respectively),
at the 4 hr post-infection time-point (Figure 2B). At the 24 hr post-
infection time-point, the average expression of CCL2, CCL5,
CCL13 and CCL19 was induced to higher levels in cells infected
with the Mtb:D-sigH mutant (59.7, 37.7, 12.3 and 13.9-fold
respectively), relative to cells infected with Mtb (39.8, 26.9, 1.5 and
2.76-fold respectively) or Mtb:D-sigH:CO (7.4, 2.2, 1.7 and 3.9-fold
respectively) (Figure 2C). At this time point, the expression of
CCL4 was not significantly different, but was numerically higher
in the mutant compared to the other two strains. Clearly, infection
with the mutant resulted in a higher expression of both inducible
and homeostatic chemokines, in the host phagocytes. These
differences are either directly or indirectly governed by the
mycobacterial SigH regulon, since genetic complementation of the
mutation reversed this differential induction of b-chemokines.
Since the microarray results, along with those of cfu analysis
overwhelmingly confirmed that the Mtb:b-sigH:CO complemented
strain elicits a transcriptional response and a replication phenotype
comparable to the parental Mtb, subsequent experiments only
addressed the differences between the parental and the mutant
strain.
Confirmation of microarray results at the transcript level
by quantitative RT-PCR
In order to confirm the results obtained in microarray studies,
we utilized pathway based quantitative PCR arrays (RT2Profi-
lerPCR arrays, SABiosciences), specific for chemokine signaling.
The expression of CCL chemokine ligands CCL2, CCL4 and
CCL7 was significantly higher in cells infected with the mutant,
relative to the cells infected with Mtb, immediately following
infection at the 0 hr time-point (Figure 2D). The expression of
CCL2, CCL5 and CCL7 remained significantly higher than in
cells infected with the mutant, relative to the cells infected with
Mtb, at the 4 hr time-point (Figure 2E). The expression of
homeostatic chemokines CCL13 and CCL19 was significantly
higher in the cells infected with the mutant, relative to the cells
infected with Mtb, at the 24 hr time-point (Figure 2F).
Confirmation of microarray results at the protein level by
confocal microscopy
Since the levels of CCL2 were consistently higher in Rh-
BMDMs infected with the Mtb:D-sigH strain in transcript assays,
we studied its expression in uninfected and infected cells at
different time-points by multilabel confocal microscopy (Fig. 3).
TOPRO-3 was used to identify cell nuclei in Rh-BMDM cultures.
We found many more cells expressing CCL2 in cultures infected
with Mtb:D-sigH for 24 hrs (Fig. 3B), relative to those infected with
Mtb (Fig. 3A).
Confirmation of microarray results at the protein level by
cytokine/chemokine assay
We performed beadarray assay on the supernatants obtained
from Rh-BMDMs infected with either Mtb or Mtb:D-sigHa t0 ,4
and 24 hr post-infection and compared the results to those
obtained from the supernatants from uninfected cells at the same
time-points to identify the levels of secreted b-chemokines. CCL2
was found to be present in significantly higher (,4-fold) levels in
the supernatants of Rh-BMDMs infected with Mtb:D-sigH,
compared to the supernatants of cells infected with Mtb, which
harbored CCL2 levels comparable to uninfected supernatants
(Figure 3C). Unlike transcript analyses, the difference at the
protein level was only apparent at the 24 hr time-point.
Induction of peripheral blood mononuclear cell (PBMC)
migration
We designed chemotaxis assays to understand the functional
relevance of higher b-chemokine expression in cells infected with
the mutant, relative to Mtb. Chemotaxis was performed using
uninfected, Mtb-infected and Mtb:D-sigH-infected cell culture
supernatants relative to cell-culture media as a negative control.
Modulation of Host Response by SigH
PLoS ONE | www.plosone.org 3 January 2012 | Volume 7 | Issue 1 | e28958Figure 2. Comparison of chemokine-expression in Rh-BMDM infected with Mtb or Mtb: D-sigH at the RNA level. Expression values are
shown for DNA microarray experiments at 0 (A), 4 (B) and 24 (C) hrs. Results for uninfected cells are represented by blue circles, while those for Mtb,
the mutant and the complemented strain are represented by green, red and black circles, respectively. Values represent responses that were
statistically different from the Rh-BMDM (Mw) responses (p,0.05). Results are representative of two independent experiments. *, p,0.05; **, p,0.01,
***, p,0.001 and ****, p,0.0001. Expression values are also shown for RT-PCR experiments at 0 (D), 4 (E) and 24 (F) hrs. Results for Mtb are
represented by green open boxes while those for the mutant are represented by red boxes. RT-PCR arrays specific for the chemokines pathway were
used to confirm microarray results. GAPDH was used as the invariant housekeeping control for normalization. The figure shows the arithmetic means
6 standard deviations for two biological replicates. *, p,0.05; **, p,0.01, ***, p,0.001 and ****, p,0.0001.
doi:10.1371/journal.pone.0028958.g002
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were used for chemotaxis assays. PBMCs migrating in response to
different stimuli were phenotyped as either macrophages (CD14
+)
or lymphocytes (CD3
+) by flow cytometry. The total number of cells
migrating in response to chemotactic signal from the supernatant of
Rh-BMDMs infected for 24 hr with Mtb:D-sigH was significantly
higher than the correspondingnumber of cells from the supernatant
of cells infected with Mtb. (Figure 4A). The increased number of
migrating PBMC could be attributed to CD14
+ cells (Figure 4B).
While the number of CD14
+ cells that migrated in response to the
mutant-conditioned chemotactic signal was higher relative to Mtb-
conditioned chemotactic signal at the 0 and 4 hr time-points, these
differences were not significant. However, a statistically significant
(p,0.035), higher number (,2-fold) of CD14
+ cells migrated in
response to the mutant-conditioned chemotactic signal, relative to
the, relative to the Mtb-conditioned chemotactic signal at 24 hr.
Greater number of CD3
+ lymphocytes also migrated in response to
the mutant-derived chemotactic signal, relative to Mtb-derived- or
uninfected-chemotactic signal, but the differences were not
statistically significant (Figure 4C).
Differential expression of pro and anti-apoptotic markers
inMtb-infected,relativeto Mtb:D-sigH-infectedRh-BMDMs
The expression of PTGS2 which codes for a prostaglandin
dehydrogenase synthase, was highly induced in cells upon
infection with Mtb (32-fold at 4 hr; 60-fold at 24 hr) and the
complement (28-fold at 4 hr; 55-fold at 24 hr), relative to the
mutant (4.8-fold at 4 hr; 45-fold at 24 hr) (Fig. 5A, B,C). PTGS2 is
involved in the conversion of the pro-apoptotic arachidonic acid
into anti-apoptotic and anti-inflammatory prostaglandin sub-
strates. Therefore, we hypothesized that high levels of expression
of PTGS2 following Mtb expression may allow the pathogen to
evade innate immune response by partially inhibiting apoptosis of
infected monocytes.
The expression of pro-apoptotic caspase-encoding genes
CASP1, CASP3 and CASP6 was indeed induced to a significantly
higher level in cells infected with the Mtb:D-sigH, though the levels
of induction were not comparable to those observed for b-
chemokines. CASP1 levels were induced .4-fold in cells infected
with the Mtb:D-sigH, but only ,1.5-fold in cells infected with Mtb
and not at all with the complemented strain. CASP3 levels were
induced .2-fold in cells infected with the Mtb:D-sigH, but
remained unchanged in cells infected with either Mtb or the
complemented strain. CASP6 levels were induced .3-fold in cells
infected with the Mtb:D-sigH, but only ,2-fold in cells infected
with Mtb and the complemented strain. We therefore analyzed the
expression of numerous pro-apoptotic genes in infected cells using
RT-PCR. The expression of CASP3, CASP6, CASP7 and CASP9
was induced to higher levels in cells infected with the Mtb:D-sigH,
relative to cells infected with Mtb, at the 0 hr time-point
(Figure 6A). The expression of APAF1, CASP3, CASP6, CASP7
and CASP9 genes was induced to higher levels in cells infected
Figure 3. Comparison of the expression of CCL2 in Rh-BMDM infected with Mtb or Mtb: D-sigH at the protein level. Visualization of the
production of chemokine CCL2 (blue) in Mtb (A) or Mtb:D-sigH (B) (both in red) - exposed (Ln5
+) macrophages (green) by multilabel confocal
microscopy. CCL2 production measured by ELISA (C). Levels of CCL2 were determined in the supernatants of Rh-BMDMs with Mtb or Mtb:D-sigH by
multiplex ELISA. The figure shows the arithmetic means 6 standard deviations for three biological replicates. *, p,0.05; **, p,0.01, ***, p,0.001 and
****, p,0.0001.
doi:10.1371/journal.pone.0028958.g003
Figure 4. Chemotaxis assay. Migration of PBMCs (A) in response to supernatants from uninfected macrophages (black), macrophages infected
with Mtb (green), Mtb:D-sigH (red) relative to tissue culture medium. Values are expressed as cells/microscopic field. Similarly, values are also shown
for CD14
+ (B) and CD3
+ (C) population in the PBMCs.
doi:10.1371/journal.pone.0028958.g004
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4 (Figure 6B) and 24 (Figure 6C) hr time-points.
Confocal microscopy based TUNEL to assay for
macrophage apoptosis
Since the expression of various components of the apoptotic
pathway was induced to higher levels in Rh-BMDMs infected with
Mtb:D-sigH relative to those infected with Mtb, we examined the
extent of apoptosis in both types of infected cells, relative to un-
infected cells, as a function of time, using a confocal microscopy
based TUNEL assay (Figure 7). Significantly more apoptosis, as
measured by TUNEL positivity, was observed for cells infected
with Mtb:D-sigH at 24 hrs (Figure 7B), relative to cells infected with
Mtb (Figure 7A). Quantitative data from counting positive cells
from ten fields in each section exhibited a statistically significant
difference between from Mtb:D-sigH and Mtb (Figure 7C).
Discussion
In spite of the host mounting an extensive response against it,
Mtb is able to survive in human tissues. It is therefore considered a
highly successful pathogen. It has been hypothesized that Mtb
modulates the host’s immune response, thus interfering with
clearance of infection and allowing a persistent or latent infection
to develop [26]. Mtb is known to interfere with host signaling
pathways activated by IFNc [27], [28], [29], [30], [31] including
through the induction of negative regulators of immune signaling
e.g. Suppressors of Cytokine Signaling [32], repression of pro-
inflammatory chemokines [33] and the down-regulation of the
IFNc receptor [34].
Apart from inhibiting the IFNc pathway, Mtb also attempts to
alter other innate and adaptive immune responses [7] [8].
Recently, it has been shown that SigE, an Mtb extracytoplasmic
sigma factor related to SigH allows the pathogen to modulate host
response by partially repressing chemokine secretion [35].
Chemokines facilitate the recruitment of effector immune cells
essential for the formation of granulomas. Therefore it is not
surprising that numerous chemokine ligands and receptors are
expressed in response to Mtb infection. These include the several a-
(C-X-C-family) [36], as well as b- (C-C-family) chemokines [37].
Our data indicates that the induction of b-chemokines is
modulated by infection with Mtb. The increased expression of
CCL2, CCL4, CCL5, CCL7, CCL13 and CCL19 in cells infected
with the D-sigH mutant and the reversal of this phenomenon in a
strain where the mutation was complemented, indicates that a
SigH-dependent Mtb factor interacts with the host innate immune
system to bring about this modulation. CCL2 and CCL7 are the
primary chemoattractant signal for monocytes and macrophages,
while CCL3 is thought to be secreted by inflamed macrophages to
attract polymorphonuclear leukocytes. CCL4 is also produced by
inflamed macrophages and attracts NK cells. CCL5 is important
for protection against Mtb infections. CCL13 and CCL19 are
homeostatic chemokines with an established role in the organiza-
tion of the TB granuloma [38]. A partial downregulation of the b-
chemokine signal may be advantageous to Mtb, as it can reduce
the rate of the recruitment of activated immune cells to the site of
infection which have the potential of limiting the infection.
Alteration in a/b chemokine ratio may result in increased
neutrophil rather than monocyte recruitment, leading to a poor
control of infection [39]. This is likely to be evolutionarily more
beneficial to the pathogen as the higher number of granulomatous
lesions may directly correlate with a greater chance of reactivation.
Apoptosis is an important component of the innate immune
response against infectious agents [40]. Therefore, a pathogen that
can persist in host tissues for long periods of time, likely modulates
these responses [41]. Mtb has been shown to possess such anti-
apoptotic mechanisms [42], [43], [44]. Furthermore, Pan et al
[45] have recently shown that the susceptibility of different
genotypic mouse strains to Mtb infection is linked to their ability to
cause apoptosis. Clearly, the inhibition of macrophage apoptosis
Figure 5. Differential expression of PTGS2 in Rh-BMDMs infected with Mtb, relative to those infected with the Mtb: D-sigH mutant.
The expression of this gene is shown for 0, 4 and 24 hrs from either uninfected Rh-BMDMs (black open boxes), or cells infected with either Mtb (green
open boxes) or the mutant (red open boxes). Results are representative of two independent experiments.
doi:10.1371/journal.pone.0028958.g005
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PLoS ONE | www.plosone.org 6 January 2012 | Volume 7 | Issue 1 | e28958may be beneficial to Mtb, allowing it to persist for a longer time by
evading bactericidal activity [46] and through bypassing CD8 T-
cell priming [47], [48].
Based on these results, we hypothesize that the SigH-dependent
regulon modulates the interaction of host innate immune responses
withMtb.TheexpressionofMtbSigH isinduced ina wide-varietyof
stress conditions such as heat-shock [11], [49]; redox stress [9], [10],
low-pH[12], phagocytosis [13],[14], etc. Expression ofSigH causes
the downstream induction of .700 Mtb genes due to, including the
SigE, SigB and the Clp proteolysis regulons [15]. One or more
products of this large regulon may interact with the host immune
system. We propose that the pro-inflammatory signal following Mtb
infection is counter-balanced by the activation of PTGS2 (COX2)
[50]. COX2 not only reduces the cellular concentration of the pro-
apoptotic arachidonic acid, but has been can directly interfere with
p53 mediated apoptosis [51,52]. A recent report suggests that a
member of the Mtb PE_PGRS conserved gene family induces the
expression of COX2 in response to stress [53]. The increased
production of COX2 by Mtb-infected phagocytes may be
responsible for the modulation in apoptosis. A mutation in the
SigH regulon is able to unmask this effect.
Our results may potentially impact the field of TB vaccines
development. Mtb mutant strains such as D-sigHo rD-nuoG [43],
which induce a higher degree of apoptosis, are likely to generate a
more potent cellular immune response. In fact BCG strains lacking
one or more sigH alleles have been shown to induce greater
immune response [54], leading to a hypothesis that the
ineffectiveness of BCG vaccines may stem from the increased
immune suppression mediated by multiple copies of sigH and the
resulting increase in antioxidant levels [55]. Mtb mutants that
promote apoptosis may be more efficacious vaccine vehicles [56].
Materials and Methods
Ethics Statement
The Tulane National Primate Research Center (TNPRC)
facilities are accredited by the American Association for Accredi-
tation of Laboratory Animal Care and licensed by the US
Department of Agriculture. All animals are routinely cared for
according to the guidelines prescribed by the NIH Guide to
Laboratory Animal Care. The TNPRC conducts all research in
accordance with the recommendations of the Weatherall report -
‘‘The use of non-human primates in research’’. Bone-marrows were
collected from NHPs scheduled for regular necropsy. Animals were
humanely euthanized by the veterinary staff at the TNPRC in
accordance with endpoint policies. Euthanasia was not performed
by any of the authors of this manuscript, nor was any of the animals
assigned to the principal investigator’s study. Samples were only
collected post-euthanasia. All procedures related to Mtb were
approved by the Tulane Institutional Bio safety Committee (IBC).
Preparation and maintenance of Rh-BMDM
2 mL bone-marrow from Indian origin rhesus (Macaca mulatta)
free of SIV, STLV, Type D retrovirus and Herpes B virus, was
Figure 6. Differential expression of apoptotic genes during infection of Rh-BMDMs with Mtb, relative to infection with the Mtb:D-
sigH mutant. The temporal expression changes of apoptotic genes as determined at the 24 hr time point by RT-PCR arrays specific for (Caspase
dependent) apoptosis,to confirm microarray results at the 0 (A), 4 (B) and 24 (C) hrs. GAPDH was used as the invariant housekeeping control for
normalization. The figure shows the arithmetic means 6 standard deviations for two biological replicates. *, p,0.05; **, p,0.01, ***, p,0.001 and
****, p,0.0001.
doi:10.1371/journal.pone.0028958.g006
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(Gibco). The suspension was filtered and the filtrate consisting of
enriched macrophages was plated. Rh-BMDMs were grown in
Iscove’s modified Dulbecco’s medium (IMDM, Mediatech)
supplemented with 10% heat-inactivated fetal bovine serum
(Gibco) and 1% penicillin/streptomycin (BioWhittaker). Rh-
BMDMs were extracted using trypsin/versene, and resuspended
at a final concentration of 10
6/ml. The phenotype of the culture
cells was .95% pure macrophage type by immunophenotyping,
by the measurement of CD14, CD86, HLA-DR, and CD11b [17].
Infection of Rh-BMDMs with Mtb the Mtb: D-sigH
(mutant) and the Mtb:D-sigH:CO (complemented) strains
Mtb CDC1551, its isogenic D-sigH mutant and a complemented
strain were cultured as described [9]. Bacterial cultures and
infection of Rh-BMDMs at an MOI of 1:10 have been previously
described. After 4 h, the cells were washed extensively to remove
extracellular bacilli and either used for the 0 hr post-infection
time-point, cultured for another 4, 24 or 72 hours. Intracellular
bacteria were obtained by lysing the cells with sterile PBS
containing 0.1% saponin (Sigma). The released bacilli were serially
diluted in PBS containing 0.01% Tween-80 (Merck) and plated on
Middlebrook 7H10/OADC agar in triplicate. CFUs were counted
after 21 days of incubation at 37uC.
DNA Microarray experiments and analysis
0, 4 and 24 hr post-infection, host transcripts extracted from
,5610
6 cells using the RNeasy kit (Qiagen), were used to profile
the expression of rhesus genome using 4644 k rhesus microarrays
(Agilent) [24]. Control samples (uninfected) were labeled with Cy3,
whereas experimental samples (infected with Mtb, Mtb:D-sigHo r
Mtb:D-sigH:Co) were labeled with Cy5. The analysis methods have
previously been described in detail [24]. Raw and normalized
array results from our experiments have been deposited into the
Gene Expression Omnibus. Genes whose expression changed by
at least 2-fold (P,0.05) were considered differentially expressed in
a significant manner.
Confirmation of transcriptome results by RT-PCR
To validate transcriptome results, the human RT2ProfilerPCR
arrays for Chemokines/Receptors (PAHS-022C-12) and Apopto-
sis (PAHS-012A-12) (SA Biosciences) were employed, using an
ABI 7900 real-time PCR machine (Applied Biosystems, Foster
City, CA). The data for biological duplicates were analyzed using
the SABiosciences PCR Array Data Analysis Software (http://
www.sabiosciences.com/pcr/arrayanalysis.php).
Confirmation of transcriptome results by multiplex
cytokine analysis
Supernatants collected from cells infected with Mtb or Mtb:D-
sigH or in medium alone for 0, 4 and 24 hours were used for
quantification of secreted cytokines and chemokines using the
NHP cytokine 23 milliplex
TM map kit (Millipore) according to
manufacturer’s directions).
Chemotaxis assays
Experiments were carried out in 24-well plates with inserts, in a
humidified incubator at 37uC with 5%CO2. Control or infected
BMDM conditioned medium or supernatants (600 ml) were added
to lower compartments of 3 mm pore multiwall inserts filters
(Becton Dickinson). 100 ml freshly isolated PBMCs at 10
6/ml from
normal macaques were added to the upper compartment and
allowed to transmigrate for 2 hrs. The number and phenotype of
migrated cells was determined by staining with CD11b (Im-
munotech), CD14 (BD Pharmingen) and CD3 (Biosource) and
performing flow-cytometry as previously described [57]. Input
samples were similarly stained.
Immunofluorescence
After removal of the supernatant, uninfected or infected Rh-
BMDMs were harvested using trypsin, Brefeldin-A blocked, washed
in PBS, and fixed with 4% paraformaldehydein PBS, pH 7.0(USB)
for 5–10 minutes for the detection of chemokines. The following
dilutions of these antibodies were used: CD163–1:50 (Serotec),
Ham56–1:20 (Dako)-, CCL2–1:10 (BD) and Ln5–1:50 (Zymed).
Mtb and CD68 were stained as previously described [58].
TUNEL assay
TUNEL assay was performed using in situ cell death detection
kit, fluorescein (Roche Applied Science), according to the
Figure 7. Functional validation of differential expression of
apoptotic genes in Rh-BMDM infected with Mtb or Mtb: D-sigH
by TUNEL assay. Apoptotic macrophages show TUNEL-positive nuclei
stained green . Representative results are shown for cells infected with
Mtb (A) and the mutant (C) at the 24-hr post-infection time-point The
total number of cells (stained with TOPRO-3 for nuclear DNA in red) can
be seen for Mtb (B) as well as the mutant (D). Magnification is to a bar
scale. Percentage of macrophage undergoing apoptosis after24 hours of
exposure to Mtb or Mtb: D-sigH as quantified by in situ TUNEL assays (E).
doi:10.1371/journal.pone.0028958.g007
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from ten fields were counted from each section (more than 500
cells in all cases). All counts were made by viewing slides under
a fixed magnification of 636 (corresponding to an area of
0.05 mm
2) using a TCS-SP2 confocal microscope (Leica Micro-
systems).
Statistical tests
Statistical significance was determined using a Mann-Whitney
test in Graphpad Prism), except for microarray results where a t-
test script within Spotfire DecisionSite/S
+ Array Analyzer was
used.
Supporting Information
Figure S1 Identification of the macrophage phenotype of Rh-
BMDMs by immunofluorescence. The image shows that a large
majority of cultured Rh-BMDMs stain positive for differentiated
macrophage marker CD163 (in green). Several of these cells are
also double positive for the macrophage marker Ham56 (in red).
Inset shows a cell staining positive for both Ham56 (red) and
macrophage marker CD68 (green).
(JPG)
Table S1 (A) This table contains a comprehensive list of Rh-
BMDM genes with a higher expression in a statistically significant
manner, in early (0 h) infection with Mtb, relative to uninfected
cells. (B) This table contains a comprehensive list of Rh-BMDM
genes with a higher expression in a statistically significant manner,
in early (4 h) infection with Mtb, relative to uninfected cells.
(C)This table contains a comprehensive list of Rh-BMDM genes
with a higher expression in a statistically significant manner, in
early (24 h) infection with Mtb, relative to uninfected cells. (D) This
table contains a comprehensive list of Rh-BMDM genes with a
higher expression in a statistically significant manner, in early (0 h)
infection with Mtb: D-sigH mutant, relative to uninfected cells. (E)
This table contains a comprehensive list of Rh-BMDM genes with
a higher expression in a statistically significant manner, in early
(4 h) infection with Mtb: D-sigH mutant, relative to uninfected
cells. (F) This table contains a comprehensive list of Rh-BMDM
genes with a higher expression in a statistically significant manner,
in early (24 h) infection with Mtb: D-sigH mutant, relative to
uninfected cells. (G) This table contains a comprehensive list of
Rh-BMDM genes with a higher expression in a statistically
significant manner, in early (0 h) infection with Mtb:D-sigH:CO
complemented strain, relative to uninfected cells. (H) This table
contains a comprehensive list of Rh-BMDM genes with a higher
expression in a statistically significant manner, in early (4 h)
infection with Mtb:D-sigH:CO complemented strain, relative to
uninfected cells. (I) This table contains a comprehensive list of Rh-
BMDM genes with a higher expression in a statistically significant
manner, in early (24 h) infection with Mtb:D-sigH:CO comple-
mented strain, relative to uninfected cells.
(XLSX)
Table S2 Overlap between different microarray data sets. Data
are presented here as fold change ratio of Mtb:mutant. Regulation:
q, up; Q, down. One symbol (q/Q) indicates the regulation is
same for both the strains and two symbols (qQ/Qq) indicate
the first for Mtb and the second for the mutant strain, respectively.
(XLSX)
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